Datasets:
Upload domains/genetics/learning-graph.csv with huggingface_hub
Browse files
domains/genetics/learning-graph.csv
ADDED
|
@@ -0,0 +1,451 @@
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| 1 |
+
ConceptID,ConceptLabel,Dependencies,TaxonomyID
|
| 2 |
+
1,Genetic Inference,,FOUND
|
| 3 |
+
2,Probability in Genetics,1,PROB
|
| 4 |
+
3,Conditional Probability,2,PROB
|
| 5 |
+
4,Bayesian Reasoning,3,PROB
|
| 6 |
+
5,Prior Probability,4,PROB
|
| 7 |
+
6,Posterior Probability,4|5,PROB
|
| 8 |
+
7,Likelihood Ratio,4|6,PROB
|
| 9 |
+
8,Pedigree Analysis,1|2,PED
|
| 10 |
+
9,Autosomal Dominant Pedigree,8,PED
|
| 11 |
+
10,Autosomal Recessive Pedigree,8,PED
|
| 12 |
+
11,X-Linked Inheritance,8,PED
|
| 13 |
+
12,X-Linked Recessive Pedigree,11,PED
|
| 14 |
+
13,X-Linked Dominant Pedigree,11,PED
|
| 15 |
+
14,Carrier Probability,4|10,PED
|
| 16 |
+
15,Penetrance,8|1,PED
|
| 17 |
+
16,Incomplete Penetrance,15,PED
|
| 18 |
+
17,Expressivity,15,PED
|
| 19 |
+
18,Variable Expressivity,17,PED
|
| 20 |
+
19,Phenocopy,15|17,PED
|
| 21 |
+
20,Genetic Heterogeneity,1,PED
|
| 22 |
+
21,Locus Heterogeneity,20,PED
|
| 23 |
+
22,Allelic Heterogeneity,20,PED
|
| 24 |
+
23,Epistasis,1,PED
|
| 25 |
+
24,Duplicate Epistasis,23,PED
|
| 26 |
+
25,Complementary Epistasis,23,PED
|
| 27 |
+
26,Suppressor Epistasis,23,PED
|
| 28 |
+
27,Epistatic Pathway Analysis,23|26,PED
|
| 29 |
+
28,Complementation Test,1|23,PED
|
| 30 |
+
29,Complementation Group,28,PED
|
| 31 |
+
30,Cis-Trans Test,28,PED
|
| 32 |
+
31,Allelism,28|29,PED
|
| 33 |
+
32,Functional Allelism,31,PED
|
| 34 |
+
33,Chi-Square Test,2,PROB
|
| 35 |
+
34,Goodness of Fit Test,33,PROB
|
| 36 |
+
35,Test Cross,1,PED
|
| 37 |
+
36,Reciprocal Cross,35,PED
|
| 38 |
+
37,Null Hypothesis in Genetics,33,PROB
|
| 39 |
+
38,P-Value Interpretation,37,PROB
|
| 40 |
+
39,Modified Mendelian Ratios,23|33,PED
|
| 41 |
+
40,Lethal Alleles,1,PED
|
| 42 |
+
41,Pleiotropy,1,PED
|
| 43 |
+
42,Genetic Background Effects,23|41,PED
|
| 44 |
+
43,Age of Onset,15|16,PED
|
| 45 |
+
44,Anticipation,43,PED
|
| 46 |
+
45,Genomic Imprinting,66,PED
|
| 47 |
+
46,Parent of Origin Effects,45,PED
|
| 48 |
+
47,Uniparental Disomy,45|106,PED
|
| 49 |
+
48,Mosaicism,1,PED
|
| 50 |
+
49,Somatic Mosaicism,48,PED
|
| 51 |
+
50,Germline Mosaicism,48,PED
|
| 52 |
+
51,Genome Organization,,FOUND
|
| 53 |
+
52,Chromosome Structure,51,GSTR
|
| 54 |
+
53,Euchromatin,52|59,GSTR
|
| 55 |
+
54,Heterochromatin,52|59,GSTR
|
| 56 |
+
55,Constitutive Heterochromatin,54,GSTR
|
| 57 |
+
56,Facultative Heterochromatin,54,GSTR
|
| 58 |
+
57,Centromere Structure,52,GSTR
|
| 59 |
+
58,Telomere Structure,52,GSTR
|
| 60 |
+
59,Chromatin,52,GSTR
|
| 61 |
+
60,Nucleosome,59,GSTR
|
| 62 |
+
61,Histone Proteins,60,GSTR
|
| 63 |
+
62,Histone Modifications,61,GSTR
|
| 64 |
+
63,Histone Acetylation,62,GSTR
|
| 65 |
+
64,Histone Methylation,62,GSTR
|
| 66 |
+
65,Chromatin Remodeling,62|59,GSTR
|
| 67 |
+
66,Epigenetics,62|68,GSTR
|
| 68 |
+
67,DNA Methylation,66,GSTR
|
| 69 |
+
68,CpG Islands,51,GSTR
|
| 70 |
+
69,Epigenetic Inheritance,66|67,GSTR
|
| 71 |
+
70,X-Inactivation,56|66,GSTR
|
| 72 |
+
71,Dosage Compensation,70,GSTR
|
| 73 |
+
72,Barr Body,70,GSTR
|
| 74 |
+
73,Genetic Variation,51,GVAR
|
| 75 |
+
74,Single Nucleotide Polymorphism,73,GVAR
|
| 76 |
+
75,Insertion Deletion Variant,73,GVAR
|
| 77 |
+
76,Copy Number Variation,73|77,GVAR
|
| 78 |
+
77,Structural Variation,73,GVAR
|
| 79 |
+
78,Chromosomal Inversion,77|52,GVAR
|
| 80 |
+
79,Chromosomal Translocation,77|52,GVAR
|
| 81 |
+
80,Chromosomal Deletion,77|52,GVAR
|
| 82 |
+
81,Chromosomal Duplication,77|52,GVAR
|
| 83 |
+
82,Tandem Repeat,73,GVAR
|
| 84 |
+
83,Short Tandem Repeat,82,GVAR
|
| 85 |
+
84,Microsatellite,83,GVAR
|
| 86 |
+
85,Minisatellite,82,GVAR
|
| 87 |
+
86,Variable Number Tandem Repeat,85,GVAR
|
| 88 |
+
87,Haplotype,74,GVAR
|
| 89 |
+
88,Haplotype Block,87|89,GVAR
|
| 90 |
+
89,Linkage Disequilibrium,87|111,GVAR
|
| 91 |
+
90,Tag SNP,88|89,GVAR
|
| 92 |
+
91,HapMap Project,87|90,GVAR
|
| 93 |
+
92,Transposable Elements,51|73,GVAR
|
| 94 |
+
93,DNA Transposon,92,GVAR
|
| 95 |
+
94,Retrotransposon,92,GVAR
|
| 96 |
+
95,LINE Element,94,GVAR
|
| 97 |
+
96,SINE Element,94,GVAR
|
| 98 |
+
97,Alu Element,96,GVAR
|
| 99 |
+
98,Transposon Mutagenesis,92|268,GVAR
|
| 100 |
+
99,Gene Duplication,77|51,GVAR
|
| 101 |
+
100,Paralog,99,GVAR
|
| 102 |
+
101,Ortholog,99|134,GVAR
|
| 103 |
+
102,Gene Family,99|100,GVAR
|
| 104 |
+
103,Pseudogene,99,GVAR
|
| 105 |
+
104,Segmental Duplication,99|77,GVAR
|
| 106 |
+
105,Polyploidy,51|106,GVAR
|
| 107 |
+
106,Aneuploidy,52,GVAR
|
| 108 |
+
107,Trisomy,106,GVAR
|
| 109 |
+
108,Monosomy,106,GVAR
|
| 110 |
+
109,Nondisjunction,106,GVAR
|
| 111 |
+
110,Chromosomal Rearrangement,77|78|79,GVAR
|
| 112 |
+
111,Linkage,,FOUND
|
| 113 |
+
112,Genetic Linkage,111|52,MAP
|
| 114 |
+
113,Recombination,111,MAP
|
| 115 |
+
114,Crossing Over,113|52,MAP
|
| 116 |
+
115,Recombination Frequency,113|114,MAP
|
| 117 |
+
116,Genetic Map,115,MAP
|
| 118 |
+
117,Map Distance,116,MAP
|
| 119 |
+
118,Centimorgan,117,MAP
|
| 120 |
+
119,Two-Point Cross,115|35,MAP
|
| 121 |
+
120,Three-Point Cross,119,MAP
|
| 122 |
+
121,Interference,120,MAP
|
| 123 |
+
122,Coefficient of Coincidence,121,MAP
|
| 124 |
+
123,Gene Order Determination,120,MAP
|
| 125 |
+
124,Genetic Markers,73|111,MAP
|
| 126 |
+
125,Molecular Markers,124,MAP
|
| 127 |
+
126,Restriction Fragment Length,125,MAP
|
| 128 |
+
127,Microsatellite Markers,84|125,MAP
|
| 129 |
+
128,SNP Markers,74|125,MAP
|
| 130 |
+
129,Physical Map,116|125,MAP
|
| 131 |
+
130,Cytogenetic Map,52|129,MAP
|
| 132 |
+
131,Radiation Hybrid Mapping,129,MAP
|
| 133 |
+
132,Somatic Cell Hybridization,131,MAP
|
| 134 |
+
133,Synteny,129|134,MAP
|
| 135 |
+
134,Comparative Genomics,306|129,MAP
|
| 136 |
+
135,Gene Discovery Strategies,124|116,MAP
|
| 137 |
+
136,Positional Cloning,135|129,MAP
|
| 138 |
+
137,Candidate Gene Approach,135,MAP
|
| 139 |
+
138,Linkage Analysis,112|124,MAP
|
| 140 |
+
139,LOD Score,138,MAP
|
| 141 |
+
140,LOD Score Threshold,139,MAP
|
| 142 |
+
141,Parametric Linkage,138,MAP
|
| 143 |
+
142,Nonparametric Linkage,138,MAP
|
| 144 |
+
143,Recombination Hotspots,113|114,MAP
|
| 145 |
+
144,Sex Differences in Mapping,116|143,MAP
|
| 146 |
+
145,Mitotic Recombination,113,MAP
|
| 147 |
+
146,Gene Conversion,113|145,MAP
|
| 148 |
+
147,Tetrad Analysis,113,MAP
|
| 149 |
+
148,Ordered Tetrad,147,MAP
|
| 150 |
+
149,Unordered Tetrad,147,MAP
|
| 151 |
+
150,Centromere Mapping,148|57,MAP
|
| 152 |
+
151,Half-Tetrad Analysis,147,MAP
|
| 153 |
+
152,Deletion Mapping,80|116,MAP
|
| 154 |
+
153,Complementation Mapping,28|116,MAP
|
| 155 |
+
154,Fine Structure Mapping,116|155,MAP
|
| 156 |
+
155,Intragenic Recombination,113,MAP
|
| 157 |
+
156,Quantitative Genetics,,FOUND
|
| 158 |
+
157,Quantitative Trait,156,QUANT
|
| 159 |
+
158,Continuous Variation,157,QUANT
|
| 160 |
+
159,Polygenic Inheritance,157|158,QUANT
|
| 161 |
+
160,Multifactorial Trait,159,QUANT
|
| 162 |
+
161,Threshold Trait,160,QUANT
|
| 163 |
+
162,Heritability,156|169,QUANT
|
| 164 |
+
163,Broad Sense Heritability,162,QUANT
|
| 165 |
+
164,Narrow Sense Heritability,162|165,QUANT
|
| 166 |
+
165,Additive Genetic Variance,169,QUANT
|
| 167 |
+
166,Dominance Variance,169,QUANT
|
| 168 |
+
167,Epistatic Variance,169|23,QUANT
|
| 169 |
+
168,Environmental Variance,169,QUANT
|
| 170 |
+
169,Phenotypic Variance,156|157,QUANT
|
| 171 |
+
170,Twin Studies,162,QUANT
|
| 172 |
+
171,Monozygotic Twins,170,QUANT
|
| 173 |
+
172,Dizygotic Twins,170,QUANT
|
| 174 |
+
173,Concordance Rate,170|171|172,QUANT
|
| 175 |
+
174,Heritability Estimation,162|170,QUANT
|
| 176 |
+
175,Quantitative Trait Locus,156|124,QUANT
|
| 177 |
+
176,QTL Mapping,175|116,QUANT
|
| 178 |
+
177,Interval Mapping,176,QUANT
|
| 179 |
+
178,Marker Assisted Selection,176|175,QUANT
|
| 180 |
+
179,GWAS,74|175|189,QUANT
|
| 181 |
+
180,Manhattan Plot,179,QUANT
|
| 182 |
+
181,Significance Threshold,179|182,QUANT
|
| 183 |
+
182,Multiple Testing Correction,179,QUANT
|
| 184 |
+
183,Bonferroni Correction,182,QUANT
|
| 185 |
+
184,False Discovery Rate,182,QUANT
|
| 186 |
+
185,Effect Size,179,QUANT
|
| 187 |
+
186,Odds Ratio,185,QUANT
|
| 188 |
+
187,Polygenic Risk Score,179|185,QUANT
|
| 189 |
+
188,Missing Heritability,162|179,QUANT
|
| 190 |
+
189,Population Genetics,,FOUND
|
| 191 |
+
190,Allele Frequency,189,POP
|
| 192 |
+
191,Genotype Frequency,190,POP
|
| 193 |
+
192,Hardy-Weinberg Equilibrium,190|191,POP
|
| 194 |
+
193,Hardy-Weinberg Assumptions,192,POP
|
| 195 |
+
194,Chi-Square HWE Test,192|33,POP
|
| 196 |
+
195,Natural Selection,189,POP
|
| 197 |
+
196,Fitness,195,POP
|
| 198 |
+
197,Selection Coefficient,196,POP
|
| 199 |
+
198,Directional Selection,195,POP
|
| 200 |
+
199,Stabilizing Selection,195,POP
|
| 201 |
+
200,Disruptive Selection,195,POP
|
| 202 |
+
201,Balancing Selection,195,POP
|
| 203 |
+
202,Heterozygote Advantage,201,POP
|
| 204 |
+
203,Genetic Drift,189,POP
|
| 205 |
+
204,Bottleneck Effect,203,POP
|
| 206 |
+
205,Founder Effect,203,POP
|
| 207 |
+
206,Gene Flow,189,POP
|
| 208 |
+
207,Migration,206,POP
|
| 209 |
+
208,Mutation Rate,189|73,POP
|
| 210 |
+
209,Population Structure,189|210,POP
|
| 211 |
+
210,Fixation Index,189|190,POP
|
| 212 |
+
211,Gene Expression,,FOUND
|
| 213 |
+
212,Transcription Regulation,211,REG
|
| 214 |
+
213,Promoter,212,REG
|
| 215 |
+
214,TATA Box,213,REG
|
| 216 |
+
215,Transcription Factor,212,REG
|
| 217 |
+
216,General Transcription Factor,215,REG
|
| 218 |
+
217,Specific Transcription Factor,215,REG
|
| 219 |
+
218,Activator,217,REG
|
| 220 |
+
219,Repressor,217,REG
|
| 221 |
+
220,Enhancer,212|217,REG
|
| 222 |
+
221,Silencer,212|219,REG
|
| 223 |
+
222,Insulator,220|221,REG
|
| 224 |
+
223,Cis-Regulatory Element,220|213,REG
|
| 225 |
+
224,Trans-Acting Factor,215,REG
|
| 226 |
+
225,Transcriptional Logic,220|226,REG
|
| 227 |
+
226,Combinatorial Control,215|220,REG
|
| 228 |
+
227,Gene Regulatory Network,211|215,REG
|
| 229 |
+
228,Network Motif,227,REG
|
| 230 |
+
229,Feedback Loop,228,REG
|
| 231 |
+
230,Feed-Forward Loop,228,REG
|
| 232 |
+
231,Operon Model,212,REG
|
| 233 |
+
232,Lac Operon,231,REG
|
| 234 |
+
233,Trp Operon,231,REG
|
| 235 |
+
234,Positive Regulation,218|231,REG
|
| 236 |
+
235,Negative Regulation,219|231,REG
|
| 237 |
+
236,Post-Transcriptional Reg,211,REG
|
| 238 |
+
237,RNA Splicing,236,REG
|
| 239 |
+
238,Alternative Splicing,237,REG
|
| 240 |
+
239,Exon Skipping,238,REG
|
| 241 |
+
240,RNA Editing,236,REG
|
| 242 |
+
241,mRNA Stability,236,REG
|
| 243 |
+
242,RNA Interference,236|243,MAP
|
| 244 |
+
243,MicroRNA,246,REG
|
| 245 |
+
244,Small Interfering RNA,242,REG
|
| 246 |
+
245,Long Noncoding RNA,246,REG
|
| 247 |
+
246,Noncoding RNA,211,REG
|
| 248 |
+
247,Riboswitch,246,REG
|
| 249 |
+
248,Translational Regulation,211,REG
|
| 250 |
+
249,Protein Degradation,211,REG
|
| 251 |
+
250,Ubiquitin Pathway,249,REG
|
| 252 |
+
251,Chromatin State,59|62,REG
|
| 253 |
+
252,Open Chromatin,251|63,GSTR
|
| 254 |
+
253,Closed Chromatin,251|64,GSTR
|
| 255 |
+
254,Bivalent Chromatin,251,GSTR
|
| 256 |
+
255,Poised Enhancer,220|254,GSTR
|
| 257 |
+
256,Super Enhancer,220,GSTR
|
| 258 |
+
257,Topologically Assoc Domain,251|258,GSTR
|
| 259 |
+
258,Chromatin Looping,251,GSTR
|
| 260 |
+
259,Cell Identity,260|227,REG
|
| 261 |
+
260,Cell Fate Determination,211|227,REG
|
| 262 |
+
261,Master Regulator Gene,260|215,REG
|
| 263 |
+
262,Pioneer Factor,261|251,REG
|
| 264 |
+
263,Stem Cell Gene Expression,259|211,FOUND
|
| 265 |
+
264,Differentiation,260,REG
|
| 266 |
+
265,Cellular Reprogramming,264|66,REG
|
| 267 |
+
266,Forward Genetics,,FOUND
|
| 268 |
+
267,Reverse Genetics,266,EXP
|
| 269 |
+
268,Mutagenesis Screen,266,EXP
|
| 270 |
+
269,Chemical Mutagenesis,268,EXP
|
| 271 |
+
270,EMS Mutagenesis,269,EXP
|
| 272 |
+
271,Insertional Mutagenesis,268|92,EXP
|
| 273 |
+
272,Saturation Mutagenesis,268,EXP
|
| 274 |
+
273,Enhancer Trap,271|220,EXP
|
| 275 |
+
274,Suppressor Screen,268,EXP
|
| 276 |
+
275,Modifier Screen,268|23,EXP
|
| 277 |
+
276,Genetic Mosaic Analysis,268|48,EXP
|
| 278 |
+
277,Clonal Analysis,276,EXP
|
| 279 |
+
278,Model Organism,,FOUND
|
| 280 |
+
279,Drosophila Genetics,278,EXP
|
| 281 |
+
280,Yeast Genetics,278,EXP
|
| 282 |
+
281,Mouse Genetics,278,EXP
|
| 283 |
+
282,C. Elegans Genetics,278,EXP
|
| 284 |
+
283,Zebrafish Genetics,278,EXP
|
| 285 |
+
284,Arabidopsis Genetics,278,EXP
|
| 286 |
+
285,Gene Knockout,267,EXP
|
| 287 |
+
286,Conditional Knockout,285,EXP
|
| 288 |
+
287,Knockdown,267,EXP
|
| 289 |
+
288,RNA Interference Screen,242|287,MAP
|
| 290 |
+
289,CRISPR-Cas9,267,EXP
|
| 291 |
+
290,Guide RNA Design,289,EXP
|
| 292 |
+
291,Gene Editing,289,EXP
|
| 293 |
+
292,Homology Directed Repair,291,EXP
|
| 294 |
+
293,NHEJ Repair,291,EXP
|
| 295 |
+
294,Base Editing,289,EXP
|
| 296 |
+
295,Prime Editing,289,EXP
|
| 297 |
+
296,Gene Drive,289|195,EXP
|
| 298 |
+
297,Transgenic Organism,291,EXP
|
| 299 |
+
298,Reporter Gene,297,EXP
|
| 300 |
+
299,GFP Reporter,298,EXP
|
| 301 |
+
300,Cre-Lox System,286|297,EXP
|
| 302 |
+
301,GAL4-UAS System,279|297,EXP
|
| 303 |
+
302,Functional Genomics,306|267,FOUND
|
| 304 |
+
303,Phenotype Scoring,268|278,EXP
|
| 305 |
+
304,Genetic Interaction,23|278,EXP
|
| 306 |
+
305,Synthetic Lethality,304,EXP
|
| 307 |
+
306,Genomics,,FOUND
|
| 308 |
+
307,Genome Sequencing,306,BIOINFO
|
| 309 |
+
308,Sanger Sequencing,307,BIOINFO
|
| 310 |
+
309,Next-Gen Sequencing,307,BIOINFO
|
| 311 |
+
310,Illumina Sequencing,309,BIOINFO
|
| 312 |
+
311,Long-Read Sequencing,309,BIOINFO
|
| 313 |
+
312,Whole Genome Sequencing,309,BIOINFO
|
| 314 |
+
313,Whole Exome Sequencing,309,BIOINFO
|
| 315 |
+
314,Targeted Sequencing,309,BIOINFO
|
| 316 |
+
315,Sequence Alignment,306,BIOINFO
|
| 317 |
+
316,BLAST Algorithm,315,BIOINFO
|
| 318 |
+
317,Pairwise Alignment,315,BIOINFO
|
| 319 |
+
318,Multiple Sequence Alignment,317,BIOINFO
|
| 320 |
+
319,Genome Annotation,306|315,BIOINFO
|
| 321 |
+
320,Gene Prediction,319,BIOINFO
|
| 322 |
+
321,Variant Calling,309|315,BIOINFO
|
| 323 |
+
322,VCF File Format,321,BIOINFO
|
| 324 |
+
323,FASTA File Format,306,BIOINFO
|
| 325 |
+
324,FASTQ File Format,309,BIOINFO
|
| 326 |
+
325,BAM File Format,309|315,BIOINFO
|
| 327 |
+
326,BED File Format,319,BIOINFO
|
| 328 |
+
327,Variant Annotation,321|319,BIOINFO
|
| 329 |
+
328,Variant Classification,327,BIOINFO
|
| 330 |
+
329,Benign Variant,328,BIOINFO
|
| 331 |
+
330,Pathogenic Variant,328,BIOINFO
|
| 332 |
+
331,Variant of Uncertain Sig,328,BIOINFO
|
| 333 |
+
332,Genomic Databases,306,BIOINFO
|
| 334 |
+
333,NCBI Database,332,BIOINFO
|
| 335 |
+
334,Ensembl Database,332,BIOINFO
|
| 336 |
+
335,UCSC Genome Browser,332,BIOINFO
|
| 337 |
+
336,ClinVar Database,332|328,BIOINFO
|
| 338 |
+
337,dbSNP Database,332|74,BIOINFO
|
| 339 |
+
338,Reproducible Workflows,306,BIOINFO
|
| 340 |
+
339,Pipeline Automation,338,BIOINFO
|
| 341 |
+
340,Version Control in Genomics,338,FOUND
|
| 342 |
+
341,RNA-Seq Analysis,309|211,BIOINFO
|
| 343 |
+
342,Differential Expression,341,BIOINFO
|
| 344 |
+
343,Gene Ontology,319|345,BIOINFO
|
| 345 |
+
344,Pathway Enrichment,342|343,BIOINFO
|
| 346 |
+
345,Functional Annotation,319,BIOINFO
|
| 347 |
+
346,Human Genetics,,FOUND
|
| 348 |
+
347,Mendelian Disease,346|8,CLIN
|
| 349 |
+
348,Complex Disease,346|159|179,CLIN
|
| 350 |
+
349,Genetic Counseling,346|350,CLIN
|
| 351 |
+
350,Risk Assessment,4|346,CLIN
|
| 352 |
+
351,Carrier Screening,349|14,CLIN
|
| 353 |
+
352,Newborn Screening,349,CLIN
|
| 354 |
+
353,Prenatal Genetic Testing,349,CLIN
|
| 355 |
+
354,Preimplantation Diagnosis,353,CLIN
|
| 356 |
+
355,Family History Assessment,8|349,CLIN
|
| 357 |
+
356,Pedigree Construction,8|355,PED
|
| 358 |
+
357,Genetic Testing Types,346,CLIN
|
| 359 |
+
358,Diagnostic Testing,357,CLIN
|
| 360 |
+
359,Predictive Testing,357,CLIN
|
| 361 |
+
360,Presymptomatic Testing,359,CLIN
|
| 362 |
+
361,Pharmacogenomics,346|211,FOUND
|
| 363 |
+
362,Drug Metabolism Variation,361,CLIN
|
| 364 |
+
363,CYP450 Polymorphisms,362|74,CLIN
|
| 365 |
+
364,Dosage Optimization,361|362,CLIN
|
| 366 |
+
365,Adverse Drug Reaction,362,CLIN
|
| 367 |
+
366,Companion Diagnostics,361|368,CLIN
|
| 368 |
+
367,Precision Medicine,346|361,CLIN
|
| 369 |
+
368,Targeted Therapy,367,CLIN
|
| 370 |
+
369,Biomarker Discovery,367|179,CLIN
|
| 371 |
+
370,Cancer Genetics,346,CLIN
|
| 372 |
+
371,Oncogene,370,CLIN
|
| 373 |
+
372,Tumor Suppressor Gene,370,CLIN
|
| 374 |
+
373,Two-Hit Hypothesis,372,CLIN
|
| 375 |
+
374,Somatic Mutation in Cancer,370|49,CLIN
|
| 376 |
+
375,Driver Mutation,374,CLIN
|
| 377 |
+
376,Passenger Mutation,374,CLIN
|
| 378 |
+
377,Tumor Mutational Burden,374|375,CLIN
|
| 379 |
+
378,Microsatellite Instability,84|374,CLIN
|
| 380 |
+
379,Lynch Syndrome,378|383,CLIN
|
| 381 |
+
380,BRCA Genes,372|383,CLIN
|
| 382 |
+
381,Liquid Biopsy,370,CLIN
|
| 383 |
+
382,Circulating Tumor DNA,381,CLIN
|
| 384 |
+
383,Hereditary Cancer Syndrome,370|372,CLIN
|
| 385 |
+
384,Chromosomal Instability,370|110,CLIN
|
| 386 |
+
385,Cancer Predisposition,383|370,CLIN
|
| 387 |
+
386,Genetic Risk Factor,179|346,CLIN
|
| 388 |
+
387,Polygenic Disease Risk,187|348,CLIN
|
| 389 |
+
388,Gene Therapy,291|346,CLIN
|
| 390 |
+
389,Antisense Therapy,388|246,CLIN
|
| 391 |
+
390,Gene Replacement Therapy,388,CLIN
|
| 392 |
+
391,Genetic Ethics,,FOUND
|
| 393 |
+
392,Informed Consent,391,ETHICS
|
| 394 |
+
393,Genetic Privacy,391,ETHICS
|
| 395 |
+
394,Genetic Discrimination,393,ETHICS
|
| 396 |
+
395,GINA Legislation,394,ETHICS
|
| 397 |
+
396,Data Ownership,393,ETHICS
|
| 398 |
+
397,Biobank Ethics,391|396,ETHICS
|
| 399 |
+
398,Return of Results,392|349,ETHICS
|
| 400 |
+
399,Incidental Findings,398,ETHICS
|
| 401 |
+
400,Duty to Warn,398|394,ETHICS
|
| 402 |
+
401,Equity in Genomic Medicine,391,ETHICS
|
| 403 |
+
402,Health Disparities,401,ETHICS
|
| 404 |
+
403,Diversity in Genomics,401,FOUND
|
| 405 |
+
404,Reference Genome Bias,403|306,ETHICS
|
| 406 |
+
405,Ancestry and Identity,189|391,ETHICS
|
| 407 |
+
406,Gene Editing Ethics,291|391,ETHICS
|
| 408 |
+
407,Germline Editing Debate,406,ETHICS
|
| 409 |
+
408,Somatic Gene Editing,406,EXP
|
| 410 |
+
409,Enhancement vs Therapy,406,ETHICS
|
| 411 |
+
410,Eugenics History,391,ETHICS
|
| 412 |
+
411,DTC Genetic Testing,346|391,ETHICS
|
| 413 |
+
412,DTC Testing Regulation,411,ETHICS
|
| 414 |
+
413,Genetic Literacy,391,ETHICS
|
| 415 |
+
414,Public Engagement,413,ETHICS
|
| 416 |
+
415,Science Communication,413,ETHICS
|
| 417 |
+
416,CRISPR Advancements,289,FRONT
|
| 418 |
+
417,CRISPR Therapeutics,416|388,FRONT
|
| 419 |
+
418,In Vivo Gene Editing,416,FRONT
|
| 420 |
+
419,Epigenome Editing,416|66,FRONT
|
| 421 |
+
420,Single-Cell Genomics,306,FOUND
|
| 422 |
+
421,Single-Cell RNA Sequencing,420|341,FRONT
|
| 423 |
+
422,Spatial Transcriptomics,421,FRONT
|
| 424 |
+
423,Cell Atlas Projects,420|421,FRONT
|
| 425 |
+
424,AI in Genomics,306,FOUND
|
| 426 |
+
425,Machine Learning Variants,424|321,FRONT
|
| 427 |
+
426,Deep Learning in Genomics,424,FOUND
|
| 428 |
+
427,Large Language Models Bio,426,FRONT
|
| 429 |
+
428,Protein Structure AI,426,FRONT
|
| 430 |
+
429,Long-Read Genomics,311,FOUND
|
| 431 |
+
430,Pangenome,306|73,FRONT
|
| 432 |
+
431,Pangenome Reference,430,FRONT
|
| 433 |
+
432,Structural Variant Calling,321|77,FRONT
|
| 434 |
+
433,Telomere-to-Telomere,58|311,FRONT
|
| 435 |
+
434,Metagenomics,306,FOUND
|
| 436 |
+
435,Microbiome Genetics,434,FRONT
|
| 437 |
+
436,Gene Regulation Atlas,227|420,FRONT
|
| 438 |
+
437,4D Nucleome,257|420,FRONT
|
| 439 |
+
438,Synthetic Genomics,306|291,FOUND
|
| 440 |
+
439,Xenotransplantation,291|391,FRONT
|
| 441 |
+
440,Emerging Research Methods,306,FRONT
|
| 442 |
+
441,Experimental Design,266|1,EXP
|
| 443 |
+
442,Hypothesis Testing,441|37,EXP
|
| 444 |
+
443,Data Interpretation,442|33,BIOINFO
|
| 445 |
+
444,Research Ethics,391|441,ETHICS
|
| 446 |
+
445,Scientific Communication,443|415,ETHICS
|
| 447 |
+
446,Computational Workflow,338|339,BIOINFO
|
| 448 |
+
447,Variant Interpretation,328|350,CLIN
|
| 449 |
+
448,Genotype-Phenotype Models,1|211|156,CLIN
|
| 450 |
+
449,Systems Genetics,227|175|189,CLIN
|
| 451 |
+
450,Capstone Genomic Project,446|447|448,FRONT
|